KYTX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.
Portfolio Pulse from
Kessler Topaz Meltzer & Check, LLP has announced a securities class action lawsuit against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) related to its February 2024 IPO. Investors who purchased Kyverna stock are reminded of the lead plaintiff deadline on February 7, 2025.
December 19, 2024 | 2:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Kyverna Therapeutics, Inc. related to its February 2024 IPO. Investors are reminded of the lead plaintiff deadline on February 7, 2025.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and reputational damage. The lawsuit is directly related to Kyverna's IPO, making it highly relevant and important for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100